Galderma Investigational Site 9980

Middlebury, Connecticut 06762

0 studies enrolling now · 1 studies all time

What they study most

Chronic Kidney Disease Associated Moderate to Severe Pruritus

Studies at this site

• To Evaluate the Efficacy and Safety of Nemolizumab for 12 Weeks in Participants With Chronic Kidney Disease With Associated Moderate to Severe Pruritus — Completed